NCT07503353
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07503353
Title A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sheba Medical Center
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries ISR

Facility Status City State Zip Country Details
Sheba Medical Center Ramat Gan Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field